| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABHD6
|
abhydrolase domain containing 6
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACO1
|
aconitase 1, soluble
|
|
ACOT7
|
acyl-CoA thioesterase 7
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTB
|
actin, beta
|
|
ACTG1
|
actin gamma 1
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFG3L2
|
AFG3-like AAA ATPase 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGR3
|
anterior gradient 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIM2
|
absent in melanoma 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ALYREF
|
Aly/REF export factor
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle)
|
|
ANKRD26
|
ankyrin repeat domain 26
|
|
ANXA10
|
annexin A10
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP10
|
aquaporin 10
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARFGAP1
|
ADP-ribosylation factor GTPase activating protein 1
|
|
ARFGAP2
|
ADP-ribosylation factor GTPase activating protein 2
|
|
ARFGAP3
|
ADP-ribosylation factor GTPase activating protein 3
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ART3
|
ADP-ribosyltransferase 3
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ASB4
|
ankyrin repeat and SOCS box containing 4
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
|
ATF1
|
activating transcription factor 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAN
|
brevican
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BGN
|
biglycan
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BTD
|
biotinidase
|
|
BTNL2
|
butyrophilin-like 2
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C3
|
complement component 3
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CABP1
|
calcium binding protein 1
|
|
CABP7
|
calcium binding protein 7
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALB2
|
calbindin 2
|
|
CALD1
|
caldesmon 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALN1
|
calneuron 1
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBX5
|
chromobox homolog 5
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNT1
|
cyclin T1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD1A
|
CD1a molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD52
|
CD52 molecule
|
|
CD7
|
CD7 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD81
|
CD81 molecule
|
|
CD8B
|
CD8b molecule
|
|
CD96
|
CD96 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDV3
|
CDV3 homolog (mouse)
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERK
|
ceramide kinase
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFL2
|
cofilin 2 (muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHMP4C
|
charged multivesicular body protein 4C
|
|
CHRDL2
|
chordin-like 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHST11
|
carbohydrate (chondroitin 4) sulfotransferase 11
|
|
CHST12
|
carbohydrate (chondroitin 4) sulfotransferase 12
|
|
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLCN6
|
chloride channel, voltage-sensitive 6
|
|
CLDN1
|
claudin 1
|
|
CLDN12
|
claudin 12
|
|
CLDN18
|
claudin 18
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN7
|
claudin 7
|
|
CLDN8
|
claudin 8
|
|
CLDND1
|
claudin domain containing 1
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CLU
|
clusterin
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
|
CNPY3
|
canopy FGF signaling regulator 3
|
|
CNPY4
|
canopy FGF signaling regulator 4
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRX
|
cone-rod homeobox
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSPP1
|
centrosome and spindle pole associated protein 1
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTF1
|
cardiotrophin 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CUL4A
|
cullin 4A
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane)
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYTH2
|
cytohesin 2
|
|
CYTH3
|
cytohesin 3
|
|
DBF4
|
DBF4 zinc finger
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DCTN1
|
dynactin 1
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT4L
|
DNA-damage-inducible transcript 4-like
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLX3
|
distal-less homeobox 3
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DPPA2
|
developmental pluripotency associated 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSC2
|
desmocollin 2
|
|
DSG2
|
desmoglein 2
|
|
DSP
|
desmoplakin
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
EDA
|
ectodysplasin A
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPHA7
|
EPH receptor A7
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPO
|
erythropoietin
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERCC8
|
excision repair cross-complementation group 8
|
|
ERF
|
Ets2 repressor factor
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV3
|
ets variant 3
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHL1
|
four and a half LIM domains 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP10
|
FK506 binding protein 10, 65 kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXE1
|
forkhead box E1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FRZB
|
frizzled-related protein
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
GDF11
|
growth differentiation factor 11
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF6
|
growth differentiation factor 6
|
|
GDF7
|
growth differentiation factor 7
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFOD2
|
glucose-fructose oxidoreductase domain containing 2
|
|
GGT2
|
gamma-glutamyltransferase 2
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHRLOS
|
ghrelin opposite strand/antisense RNA
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRA2
|
glycine receptor, alpha 2
|
|
GLRX3
|
glutaredoxin 3
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPC1
|
glypican 1
|
|
GPC3
|
glypican 3
|
|
GPS2
|
G protein pathway suppressor 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRID2IP
|
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRXCR2
|
glutaredoxin, cysteine rich 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GUCA2A
|
guanylate cyclase activator 2A (guanylin)
|
|
H1F0
|
H1 histone family, member 0
|
|
H1FX
|
H1 histone family, member X
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBFQTL4
|
Fetal hemoglobin QTL on chromosome 8
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HK1
|
hexokinase 1
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXA1
|
homeobox A1
|
|
HOXB7
|
homeobox B7
|
|
HOXD10
|
homeobox D10
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR3D
|
5-hydroxytryptamine (serotonin) receptor 3D, ionotropic
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
IAPP
|
islet amyloid polypeptide
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBC
|
inhibin, beta C
|
|
INHBE
|
inhibin, beta E
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1
|
|
ITM2B
|
integral membrane protein 2B
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAK2
|
Janus kinase 2
|
|
JPH3
|
junctophilin 3
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNMB2
|
potassium channel subfamily M regulatory beta subunit 2
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLB
|
klotho beta
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLHDC1
|
kelch domain containing 1
|
|
KLHDC2
|
kelch domain containing 2
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK15
|
kallikrein-related peptidase 15
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT7
|
keratin 7, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LACTB
|
lactamase, beta
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC26
|
leucine rich repeat containing 26
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGST1
|
microsomal glutathione S-transferase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1
|
|
MICAL2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2
|
|
MIER1
|
mesoderm induction early response 1, transcriptional regulator
|
|
MIR125A
|
microRNA 125a
|
|
MIR140
|
microRNA 140
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR183
|
microRNA 183
|
|
MIR185
|
microRNA 185
|
|
MIR190A
|
microRNA 190a
|
|
MIR203A
|
microRNA 203a
|
|
MIR21
|
microRNA 21
|
|
MIR223
|
microRNA 223
|
|
MIR24-2
|
microRNA 24-2
|
|
MIR31
|
microRNA 31
|
|
MIR34C
|
microRNA 34c
|
|
MIR379
|
microRNA 379
|
|
MIR95
|
microRNA 95
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLNR
|
motilin receptor
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSN
|
moesin
|
|
MSTN
|
myostatin
|
|
MT1G
|
metallothionein 1G
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR2
|
myotubularin related protein 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC15
|
mucin 15, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC20
|
mucin 20, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MVK
|
mevalonate kinase
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYO3A
|
myosin IIIA
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NAT8
|
N-acetyltransferase 8 (GCN5-related, putative)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NES
|
nestin
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-2
|
NK2 homeobox 2
|
|
NKX2-3
|
NK2 homeobox 3
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1L1
|
NPC1-like 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPM2
|
nucleophosmin/nucleoplasmin 2
|
|
NPPB
|
natriuretic peptide B
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRL
|
neural retina leucine zipper
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NT5C3A
|
5'-nucleotidase, cytosolic IIIA
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUF2
|
NUF2, NDC80 kinetochore complex component
|
|
NUP98
|
nucleoporin 98kDa
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa
|
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
OCLN
|
occludin
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OLFM4
|
olfactomedin 4
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OXTR
|
oxytocin receptor
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PAX8
|
paired box 8
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDCD6
|
programmed cell death 6
|
|
PDCL
|
phosducin-like
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PENK
|
proenkephalin
|
|
PEPD
|
peptidase D
|
|
PER2
|
period circadian clock 2
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF2
|
PHD finger protein 2
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PLSCR3
|
phospholipid scramblase 3
|
|
PLXNB1
|
plexin B1
|
|
PML
|
promyelocytic leukemia
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPOX
|
protoporphyrinogen oxidase
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PRDM9
|
PR domain containing 9
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1
|
|
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PSMD7
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PURG
|
purine-rich element binding protein G
|
|
PXN
|
paxillin
|
|
PZP
|
pregnancy-zone protein
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAP2B
|
RAP2B, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RAVER1
|
ribonucleoprotein, PTB-binding 1
|
|
RB1
|
retinoblastoma 1
|
|
RBMY1A1
|
RNA binding motif protein, Y-linked, family 1, member A1
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RDH8
|
retinol dehydrogenase 8 (all-trans)
|
|
RDM1
|
RAD52 motif containing 1
|
|
RDX
|
radixin
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOH
|
ras homolog family member H
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF14
|
ring finger protein 14
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RNR1
|
RNA, ribosomal cluster 1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SATB1
|
SATB homeobox 1
|
|
SATB2
|
SATB homeobox 2
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCTR
|
secretin receptor
|
|
SCUBE1
|
signal peptide, CUB domain, EGF-like 1
|
|
SDC1
|
syndecan 1
|
|
SDC3
|
syndecan 3
|
|
SECISBP2
|
SECIS binding protein 2
|
|
SELPLG
|
selectin P ligand
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SENP3
|
SUMO1/sentrin/SMT3 specific peptidase 3
|
|
SENP7
|
SUMO1/sentrin specific peptidase 7
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SFN
|
stratifin
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SH2D3A
|
SH2 domain containing 3A
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT5
|
sirtuin 5
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14
|
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLX4IP
|
SLX4 interacting protein
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMTN
|
smoothelin
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORBS1
|
sorbin and SH3 domain containing 1
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP4
|
Sp4 transcription factor
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPATA12
|
spermatogenesis associated 12
|
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPON1
|
spondin 1, extracellular matrix protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQLE
|
squalene epoxidase
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
SRSF9
|
serine/arginine-rich splicing factor 9
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST2
|
suppression of tumorigenicity 2
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK3
|
serine/threonine kinase 3
|
|
STMN1
|
stathmin 1
|
|
STOX1
|
storkhead box 1
|
|
SULF2
|
sulfatase 2
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC4
|
tachykinin 4 (hemokinin)
|
|
TACR1
|
tachykinin receptor 1
|
|
TAF4
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa
|
|
TAF4B
|
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R39
|
taste receptor, type 2, member 39
|
|
TAS2R8
|
taste receptor, type 2, member 8
|
|
TAZ
|
tafazzin
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX101
|
testis expressed 101
|
|
TF
|
transferrin
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
TGS1
|
trimethylguanosine synthase 1
|
|
TH
|
tyrosine hydroxylase
|
|
THOC1
|
THO complex 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLN2
|
talin 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNMD
|
tenomodulin
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNS2
|
tensin 2
|
|
TNS3
|
tensin 3
|
|
TNXB
|
tenascin XB
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN1
|
tetraspanin 1
|
|
TST
|
thiosulfate sulfurtransferase (rhodanese)
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYMS
|
thymidylate synthetase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
U2AF1L4
|
U2 small nuclear RNA auxiliary factor 1-like 4
|
|
UBAP1
|
ubiquitin associated protein 1
|
|
UBTF
|
upstream binding transcription factor, RNA polymerase I
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UMOD
|
uromodulin
|
|
UNG
|
uracil-DNA glycosylase
|
|
UPK2
|
uroplakin 2
|
|
USF1
|
upstream transcription factor 1
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
UTS2R
|
urotensin 2 receptor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VWF
|
von Willebrand factor
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT2B
|
wingless-type MMTV integration site family, member 2B
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YBX1
|
Y box binding protein 1
|
|
YEATS4
|
YEATS domain containing 4
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
|
ZNF224
|
zinc finger protein 224
|
|
ZRANB2
|
zinc finger, RAN-binding domain containing 2
|
